Difference between revisions of "Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5 (Q9888)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 23575478, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 2766-2774, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2013
Timestamp+2013-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2013 / rank
 +
Normal rank
Property / Published In Name String
 +
Clin. Cancer Res.
Property / Published In Name String: Clin. Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
19
Property / Volume: 19 / rank
 +
Normal rank
Property / title
 +
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English)
Property / title: Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English) / rank
 +
Normal rank
Property / Page(s)
 +
2766-2774
Property / Page(s): 2766-2774 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Jimeno A
    0 references
    0 references
    2013
    0 references
    Clin. Cancer Res.
    0 references
    19
    0 references
    Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors (English)
    0 references
    2766-2774
    0 references